Navigation Links
Hospira Reports First-Quarter 2012 Results
Date:5/1/2012

ly certain products to customers. These charges are directly associated with Hospira's response to the United States Food and Drug Administration ("FDA") 2010 warning letter and subsequent Form 483 observations and charges related to Hospira's comprehensive device product review and certain device related remediation activities.(C)

Capacity expansion related charges reported in Cost of products sold include start-up charges related to manufacturing capacity expansion in India.Three months ended March 31, 2011 Reconciliation of GAAP to Non-GAAP Financial Measures:Gross Profit (1)Income From

OperationsNet Income (2)Diluted EPSGAAP financial measures$
399.1$
3.8$
49.9$
.88Specified items:   Project Fuel and related charges (A)5.09.66.30.04   Facilities Optimization charges (B)0.81.10.70.01   Amortization and impairment of certain intangible assets (C)19.421.114.50.09   Other restructuring charges (D)-7.85.80.03   Settlement of IRS tax audit benefit (E)--(19.7)(0.12)Adjusted financial measures (3)$
424.3$
203.4$
57.5$
.93GAAP results for the three months ended March 31, 2011 include:(A)

Project Fuel and related charges: $5.0 million reported in Cost of products sold, $3.4 million reported in Restructuring, impairment and (gain) on disposition of assets, net and $1.2 million reported in Selling, general and administrative. Project Fuel initiatives include costs for process optimization implementation, severance and other employee benefits, exit costs, and other asset charges.(B)

Facilities Optimization charges: $0.8 million reported in Cost of products sold and $0.3 million reported in Restructuring, impairment and (gain) on disposition of asset
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Joins the Generic Pharmaceutical Association
3. Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Months Supply of New Product Immediately and on Track to Ensure Sustainable Supply
4. Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
5. Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
6. Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
7. Hospira Reports Third-Quarter 2011 Results
8. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
9. Hospira to Host Conference Call for Third-Quarter 2011 Results
10. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
11. Hospira to Host 2011 Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... Auf seiner am ... veranstalteten F&E-Tagung meldete Astellas Fortschritte im ... Forschungsrahmenprogramms. Die Tagung bot Astellas die Gelegenheit, ... Programme und die Konzernstrategie des Unternehmens zu ... aktuelle Meldungen zu den Astellas-Initiativen in den ...
(Date:7/13/2014)... 13, 2014  Eli Lilly and Company (NYSE: ... its non-clinical study in genetically engineered mice examining ... beta-amyloid antibody N3pG and beta-secretase inhibitor BACE (LY2811376). ... effective in removing clumps of amyloid-beta protein in ... to lead to Alzheimer,s disease (AD) – than ...
(Date:7/11/2014)... LOS ANGELES , July 11, 2014 /PRNewswire-iReach/ ... of e-liquid, a vegetable-glycol solution for use in ... one of the active ingredients in cannabis, cannabidiol ... in personal vaporizer devices, and other vaporizer technology. ... Cannabis naturally contains 483 different compounds ...
Breaking Medicine Technology:Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 2Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 3Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 4New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2
(Date:7/13/2014)... New York (PRWEB) July 13, 2014 ... bring attention to the cancer risks associated with power ... to tell their story to federal regulators, as they ... U.S. Food & Drug Administration (FDA) advisory panel ... reports. According to the Rochester Democrat and Chronicle, ...
(Date:7/13/2014)... Athletes with a certain genetic make-up are prone ... research presented today at the American Orthopaedic Society for ... marks the first of its kind investigating a genetic ... that occur after a head injury. , “We ... (GT)n genotype were four times more likely to have ...
(Date:7/13/2014)... Trujillo Alto, Puerto Rico (PRWEB) July 13, 2014 ... that NBA Hall of Famer, Chris Mullin, will be ... Meeting on Saturday, July 26th in Puerto Rico. ... opportunities. Chris Mullin will participate in two exhibition basketball ... Max International, the ultimate supplier of health- and ...
(Date:7/13/2014)... Dallas, Texas (PRWEB) July 13, 2014 ... of aGVHD in the 6MM, from 8,062 diagnosed incident ... 2023, at an Annual Growth Rate (AGR) of 4.35%, ... have the highest number of diagnosed incident cases of ... whereas Spain will have the lowest number of diagnosed ...
(Date:7/13/2014)... July 13, 2014 According to the Kidney ... a step by step guide on what to do to ... and quickly. Vkool writes in its review that readers can ... eat to revitalize their kidney health. Vkool also informs in ... people reverse their damaged kidney functions naturally. The book consists ...
Breaking Medicine News(10 mins):Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 2Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 4Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 3Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 4Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3
... float the first 'global health bonds' to raise $ 4 ... poor, and strengthen global immunization efforts.// ,The move will ... world to become part of the efforts to make healthcare ... investment. ,Giving information about the bonds that are ...
... of Washington University writes in his latest book Doctor’s ... has been a great scientist, inventor, publisher and statesman.// ... education has contributed a lot to preventive and modern ... America during the 18th Century in a period where ...
... Improvement has funded a grant of $30,000 to Medical ... Care to understand the usefulness of online information systemhas ... online information system woulc be helpulf for managing multiple ... to apply and the 20 selected for support from ...
... by Brian Carpenter, Ph.D., of the Washington University in St. ... two adult siblings with regard to their parents’ wants. // ... across. There is nothing which clearly indicates as to which ... wants. ,The children who feel that they ...
... the brain spring into action when one if faced with ... Hsu of the California Institute of Technology in Pasadena and ... betting games. As they played, the scientists watched changes in ... one game, researchers gave them the chance to guess the ...
... basic vaccines and introduce three new ones.,"We will give India ... will provide $40 million and then more than double it ... ,Addressing a press conference after the conclusion of the ... made a lot of progress in the vaccination and immunization ...
Cached Medicine News:Health News:Health bonds to immunize the poor 2Health News:Online information system for patients 2Health News:Adult Children Fail to Understand Parents Wishes 2
Anti Gliadin IgG Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum....
... the semi-quantitative determination of specific IgA autoantibodies ... of the anti-Gliadin IgA assay can be ... of diseases associated with elevated levels of ... these autoantibodies are one indicator in a ...
... kit is used for the quantitative measurement ... plasma. This Free Estriol kit is a ... and controls are incubated with Estriol enzyme ... antibody. Free Estriol in the patients serum ...
... The Urisys 1800 System is the ... daily urinalysis workload in a convenient and ... is designed for optimized work and data ... sediment terminal.Fast processing of test strips accelerates ...
Medicine Products: